Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides
M. A. Carroll, M. Balazy, P. Margiotta, D. D. Huang, J. R. Falck and J. C. McGiff Department of Pharmacology, New York Medical College, Valhalla 10595, USA. The cytochrome P-450 pathway is capable of metabolizing arachidonic acid to omega- and subterminal hydroxylase metabolites, 16-, 17-, 18-, 19-,...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 1996-10, Vol.271 (4), p.863-R869 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | M. A. Carroll, M. Balazy, P. Margiotta, D. D. Huang, J. R. Falck and J. C. McGiff
Department of Pharmacology, New York Medical College, Valhalla 10595, USA.
The cytochrome P-450 pathway is capable of metabolizing arachidonic acid to
omega- and subterminal hydroxylase metabolites, 16-, 17-, 18-, 19-, and
20-hydroxyeicosatetraenoic acids (P-450 HETEs). We have quantitated, by gas
chromatography-mass spectrometry (GC/MS), endogenous HETEs exiting the
rabbit isolated perfused kidney elicited by hormonal stimulation. Kidneys
were perfused with Krebs-Henseleit solution containing indomethacin (2.8
microM) to prevent further metabolism of HETEs by cyclooxygenase.
Phenylephrine (2-3 microM) was added to the perfusate to raise perfusion
pressure to approximately 80 mmHg. Angiotensin II (ANG II), arginine
vasopressin (AVP), and bradykinin (BK) were injected into the renal artery
and perfusates collected throughout the vasoactive response. After addition
of an internal standard, deuterated 19-HETE, perfusates were extracted and
purified and P-450 HETEs were derivatized for GC/MS analysis. Under basal
conditions, 16-, 18-, 19-, and 20-HETEs were released (range: 50-270
pg/ml), 19-HETE being the highest and fivefold greater than 16-HETE, the
lowest. Injection of 50 ng ANG II increased by two- to sixfold P-450 HETE
release associated with an increase of 40 +/- 11 mmHg in perfusion
pressure. An equipressor dose of AVP (50 ng) did not release P-450 HETEs
nor did a 5-micrograms dose of the vasodilator peptide BK, which decreased
perfusion pressure by 22 +/- 6 mmHg. Authentic 19- and 20-HETE isomers
resulted in dose-dependent dilation, as did 18(R)- and 16(R)-HETEs, whereas
their enantiomers and 17-HETE isomers were without effect on perfusion
pressure. The vasodilator effects of 18(R)- and 16(R)-HETEs, like 20- and
19-HETEs, were inhibited by indomethacin. Furthermore, P-450 HETEs
exhibited both regio- and stereoselective inhibition of proximal tubule
adenosine triphosphatase (ATPase) activity. The (S) enantiomers of 16- and
17-HETE potently inhibited activity, whereas their (R) isomers and other
P-450 HETEs had negligible effects on ATPase activity. The quantity of
HETEs released from the kidney, either under basal conditions or when
stimulated by ANG II, and their biological profile suggest that subterminal
HETEs may participate in renal mechanisms affecting vasomotion and tubular
transport. |
---|---|
ISSN: | 0363-6119 0002-9513 1522-1490 |
DOI: | 10.1152/ajpregu.1996.271.4.r863 |